Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin versus atorvastatin for diffuse coronary artery disease
ChiCTR-TRC-10001085Phase 4Completed
- Sponsor
- Xinqiao Hospital
- Start
- Jan 2011
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of rosuvastatin and atorvastatin in coronary arteriosclerosis (2 arms), sponsored by Xinqiao Hospital. Primary endpoints: coronary artery stenosis and coronary atheroma. Started Jan 2011; status: completed.
02
Drugs
rosuvastatinatorvastatin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-TRC-10001085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10001085.